Who Owns Abeona Therapeutics Stock?
NASDAQ: ABEOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 71.61%
- Held by insiders
- 12.57%
- Institutional holders
- 158
- Institutions 71.6%
- Insiders 12.6%
- Public and other 15.8%
Who owns Abeona Therapeutics stock?
Institutional investors own about 71.6% of Abeona Therapeutics's shares, spread across 158 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 12.57% of ABEO.
The largest institutional holders are Nantahala Capital Management, LLC (9.47%), Blackrock Inc. (5.91%) and Cable Car Capital, LP (5.26%). Together, the top 10 institutions control 40.7% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ABEO positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ABEO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Nantahala Capital Management, LLC | 5.41M | 9.47% | +5.3% |
| Blackrock Inc. | 3.38M | 5.91% | +0.7% |
| Cable Car Capital, LP | 3.01M | 5.26% | 0.0% |
| AIGH Capital Management LLC | 2.90M | 5.07% | -2.9% |
| Vanguard Capital Management LLC | 2.14M | 3.74% | -3.3% |
| AWM Investment Company, Inc. | 1.49M | 2.60% | +0.1% |
| Kennedy Capital Management, LLC | 1.33M | 2.33% | +7.3% |
| Geode Capital Management, LLC | 1.33M | 2.32% | +5.1% |
| Goldman Sachs Group Inc | 1.22M | 2.14% | +8.3% |
| State Street Corporation | 1.05M | 1.84% | +1.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ABEO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.53M | 2.68% |
| iShares Trust-iShares Russell 2000 ETF | 1.19M | 2.09% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 627.77K | 1.10% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 478.77K | 0.84% |
| iShares Trust-iShares Russell 2000 Value ETF | 437.93K | 0.77% |
| Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF | 345.42K | 0.60% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 249.45K | 0.44% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 237.81K | 0.42% |
| iShares Trust-iShares Micro-Cap ETF | 145.31K | 0.25% |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 120.05K | 0.21% |
Frequently asked questions
Who is the largest shareholder of Abeona Therapeutics?
Nantahala Capital Management, LLC is the largest institutional shareholder of ABEO, owning 9.47% of shares outstanding (5.41M shares) as of its latest 13F filing.
What percentage of Abeona Therapeutics is owned by institutions?
Institutions own about 71.6% of ABEO shares and 81.9% of the public float.
How much of Abeona Therapeutics do insiders own?
Insiders, such as officers and directors, own about 12.57% of ABEO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.